Galaxy Agrico Exports Ratios

Galaxy Agrico Exports Ltd Ratios

The Galaxy Agrico Exports Ltd Ratios page provides a complete fundamental analysis of Galaxy Agrico Exports Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Galaxy Agrico Exports Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Galaxy Agrico Exports Ltd (NSE: , BSE: 531911) is currently trading at ₹42.92, with a market capitalization of ₹682.03M. As a major player in the Producer manufacturing sector and Metal fabrication industry, Galaxy Agrico Exports Ltd remains a key stock for fundamental analysis using Galaxy Agrico Exports Ltd Ratios.

Galaxy Agrico Exports Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Galaxy Agrico Exports Ltd P/E ratio currently stands at 141.49, making it one of the most tracked metrics in Galaxy Agrico Exports Ltd Ratios.

Historically, the Galaxy Agrico Exports Ltd P/E ratio has shown strong fluctuations:

• 2024: 141.49
• 2023: 6.76
• 2022: 3.98
• 2021: 14.20
• 2020: 3.40

The rising Galaxy Agrico Exports Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Galaxy Agrico Exports Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 2.87.

Historical P/B trend:

• 2024: 2.87
• 2023: 3.30
• 2022: 1.24
• 2021: 1.80

Galaxy Agrico Exports Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Galaxy Agrico Exports Ltd P/S ratio currently stands at 3.22, an important part of Galaxy Agrico Exports Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 3.22
• 2023: 1.86
• 2022: 1.01
• 2021: 1.29

The rising Galaxy Agrico Exports Ltd P/S ratio indicates improved revenue valuation by investors.

Galaxy Agrico Exports Ltd Price to Cash Flow Ratio (P/CF)

The Galaxy Agrico Exports Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Galaxy Agrico Exports Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 7.32
• 2022: 5.25
• 2021: 6.71
• 2020: 0

The declining Galaxy Agrico Exports Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Galaxy Agrico Exports Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Galaxy Agrico Exports Ltd EV currently stands at ₹131.23M, representing the total company valuation including debt.

Historical EV trend:

• 2024: 131.23M
• 2023: 150.26M
• 2022: 64.59M
• 2021: 85.82M

Galaxy Agrico Exports Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Galaxy Agrico Exports Ltd EV/EBITDA ratio is currently 93.33, a key metric in Galaxy Agrico Exports Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 93.33
• 2023: 6.23
• 2022: 3.99
• 2021: 10.62

Higher Galaxy Agrico Exports Ltd EV/EBITDA suggests premium valuation.

Galaxy Agrico Exports Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Galaxy Agrico Exports Ltd D/E ratio is currently 0.45, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.45
• 2023: 0.40
• 2022: 0.23
• 2021: 0.17

Galaxy Agrico Exports Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Galaxy Agrico Exports Ltd ROE currently stands at 2%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 2
• 2023: -12.76
• 2022: 30.24
• 2021: 13.45

Declining ROE indicates pressure on profitability.

Galaxy Agrico Exports Ltd Ratios Analysis Summary

The Galaxy Agrico Exports Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Galaxy Agrico Exports Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Galaxy Agrico Exports Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.